SCHD: The Perfect Macro Storm Ahead

Schwab US Dividend Equity ETF faces tariff-policy uncertainty and Fed balance-sheet unwind risks. See more investment ...
pharmaphorum

Flagship's AI-focused Generate Biomedicines files IPO

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...